Stocks/ALAB

ALAB three-lens brief

Evidence-based stock research on ALAB. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

52-week rangeas of 08:00 ET
$97.89$284.53$499.48

Performance

1W
+0.6%
1M
-8.8%
3M
6M
YTD
1Y
3Y
5Y
ALAB · Nightly brief
Inspect

Price down 5.33% in the last session — a material single-day move. · Trading >3% below the 50-day MA — short-term weakness.

  • Price down 5.33% in the last session — a material single-day move.
  • Trading >3% below the 50-day MA — short-term weakness.
  • Outperforming SPY by 10.0pp over 30 days.
  • P/E of 147 — priced for high growth; little margin of safety.
  • Analyst mean target $389.95 — 37% above current (23 analysts).

ALAB closed at $284.53 (-5.33%) as of 2026-09-11. Market cap: $49.36B. P/E (trailing) 147.4. Price is below the 50-day MA and above the 200-day MA. Positives: outperforming SPY by 10.0pp over 30 days.; analyst mean target $389.95 — 37% above current (23 analysts).. Concerns: price down 5.33% in the last session — a material single-day move.; trading >3% below the 50-day MA — short-term weakness.. Last quarter: Revenue $392.40M, net income $153.09M, free cash flow $91.91M.

Market ✓· Fundamentals ✓
Informational only · Not investment advice
Three-lens method

Why three lenses on ALAB, not one.

A single reasoning model has blind spots it doesn’t know about. We examine ALABacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology
Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://clearpathinvest.app/embed/ALAB"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath ALAB brief"></iframe>